A 34% rise in cases of meticillin-resistant Staphy-lococcus aureus (MRSA) and meticillin-susceptible 5. aureus (MSSA) infections in just three months has prompted a Scottish health board to introduce new procedures for administering intravenous drugs and fluids. The move follows recommendations from an audit, by PricewaterhouseCoopers (PwC), into NHS Greater Glasgow and Clyde's use of central venous and peripheral venous cannulae in January 2014. Official figures highlighted by Health Protection Scotland (HPS) in early January showed that the number of MRSA and MSSA cases had risen by over a third between July and September 2013 and the previous quarter.
展开▼
